| “FDA approval for chimeric antigen receptor (CAR) T cell therapy occurred 30 years after the initial research began. Prior to the approval, the first successful treatment using CAR T cells was in 2010 for a retired Marine with chronic leukemia. Two years later, Emily Whitehead became the first child treated and cured. Key industry leaders came together to celebrate these and other CAR T cell achievements as well as discuss the therapy’s future at the 2025 GenScript Biotech Global Forum.“ Find out more here. |
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
By
